KagedBird ✨ (@kagedbird.bsky.social)

Published in The New England Journal of Medicine. Peer-reviewed. Large sample size. Sound methodology. A daily pill DOUBLED survival time for patients with an advanced and aggressive form of pancreatic cancer when compared to chemotherapy. Daraxonrasib works by locking onto the mutated KRAS gene.

loading . . .

A new pancreatic cancer pill may be a game changer for patients Daraxonrasib, which nearly doubled patients' survival time, fights the disease in a new way. It bear-hugs a cancer protein that drives cell growth. https://www.sciencenews.org/article/pancreatic-cancer-pill-daraxonrasib

3007

964